Mounjaro Injections – Weight Loss Treatment

Price range: £189.00 through £255.00

Mounjaro Medication Features

Mounjaro is a once-weekly weight loss injection containing Tirzepatide and is now licensed for weight loss in the UK. It comes in pre-filled pens that contain 4 doses of Mounjaro and is injected ONCE weekly under the skin. Mounjaro has been clinically proven to achieve ~20% body weight loss or more and is used for Weight Management (weight loss and weight maintenance) and Type 2 diabetes.

Each pack of Mounjaro contains 4 x weekly doses plus needles

Description

Buy Mounjaro Injections online

What Is Mounjaro?

Mounjaro is a highly effective, UK licensed weight loss treatment. It has been shown in clinical trials to help achieve up to 22.5% body weight loss. It is the latest GLP-1 weight loss medication, and is used for people with a body mass index (BMI) over 30. It can also be prescribed for patients with a BMI of 27+ and a weight-related medical condition, such as high blood pressure or high cholesterol.

The active ingredient tirzepatide is a registered trademark of Eli Lilly.

It is known as Zepbound in the US, but launched in the UK under the brand name Mounjaro.

It is used ONCE weekly, as a subcutaneous (under the skin) injection. More information on how to inject Mounjaro can be found in the Patient Information Leaflet.

How It Works

Mounjaro weight loss pens mimic the action of GLP-1, a natural hormone produced in the gut. This innovative treatment promotes significant weight loss for patients by acting similarly to GLP-1. Its two main effects are;

  1. It helps regulate appetite, making it easier to eat less
  2. It makes you feel fuller for longer

Both actions lead to eating fewer calories, which results in weight loss. Focusing on a reduced-calorie diet can amplify the benefits.

How Effective Is Mounjaro?

When using Mounjaro KwikPens to suppress appetite, you can expect to lose around 16-22.5% of your initial body weight after completing treatment. This is the most effective of all the released GLP-1 medications so far.

These figures have been achieved by patients who have maintained on the highest strength of Mounjaro, which is the 15mg strength.

Patients who maintain at 10mg, lose on average 21%, while patients who maintain at 15mg, can lose around 22.5%.

The lower strengths of Mounjaro 2.5 and 5mg will not achieve the best results. While some weight loss will be observed, the primary function of these doses is to help your body adjust to the drug without experiencing serious side effects.

Additional information
Dose

(4 x doses of 2.5mg)

,

(4 x doses of 5mg)

,

(4 x doses of 7.5mg)

,

(4 x doses of 10mg)

,

(4 x doses of 12.5mg)

,

(4 x doses of 15mg)

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.